Fulvestrant May Falsely Increase 17β-Estradiol Levels in Immunoassays: A Case Report of a 57-Year-Old Postmenopausal Patient With Recurrent Estrogen Receptor-Positive Breast Cancer

The prognosis for female patients with locoregionally recurrent breast cancer has improved with the concurrent local and systemic treatment under multiple disciplinary teams. Radiotherapy is a valuable local treatment measure for unresectable locoregional recurrent breast cancer; however, reirradiat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Jingxian, Cao, Yali, Guo, Yonghong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045700/
https://www.ncbi.nlm.nih.gov/pubmed/35494071
http://dx.doi.org/10.3389/fonc.2022.832763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045700/
https://www.ncbi.nlm.nih.gov/pubmed/35494071
http://dx.doi.org/10.3389/fonc.2022.832763

Ejemplares similares